The FDA announced on Feb. 8, 2024, that Beckman Coulter, Inc. is recalling Access Total T4 thyroxine reagent assays due to imprecision that may cause erroneous results. The agency issued the Class II recall for four specific lots distributed worldwide.
How to tell if you have it
- Brand: Beckman Coulter
- Product: Access Total T4, REF 33800, IVD, thyroxine reagent assay
- Lot numbers: 338555 (exp. 31 JUL 2024), 338556 (exp. 31 AUG 2024), 338734 (exp. 30 SEP 2024), and 338958 (exp. 31 OCT 2024)
- UDI-DI: 15099590225742
- Quantity: 64,009 kits
The hazard
Four lots of Access Total T4 reagent demonstrated imprecision outside of the 10% specification which may result in erroneous or delayed results. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Beckman Coulter, Inc. has 132 other recalls on record since June 20, 2017. Other recent recalls of similar products include Beckman Coulter DxC 500i Modules with Software 1.5 (July 15, 2026), Beckman Coulter MicroScan LabPro V5.03 Panel Update 11 (June 26, 2026), and Beckman Coulter Access Total T4 Calibrator Recall (March 16, 2026). Other recent recalls of similar products include Beckman Coulter Bicarbonate Reagent (Oct. 14, 2025), Roche Elecsys Anti-TSHR Assay (Nov. 21, 2025), and Beckman Coulter LDL Cholesterol Reagent (Dec. 8, 2025).